Long-term efficacy and safety of Alemtuzumab in patients with RRMS: 12-year follow-up of the CAMMS223 study

Long-term efficacy and safety of Alemtuzumab in patients with RRMS: 12-year follow-up of the CAMMS223 study / Coles, A; Berkovich, R; Carraro, M; Compston, DAS; Al Malik, Y; Fernandez, O; Ionete, C; Massacesi, L; Meuth, SG; Mitsikostas, D; Pardo, G; Simm, RF; Steingo, B; Choudhry, Z; Daizadeh, N; Traboulsee, A. - In: MULTIPLE SCLEROSIS. - ISSN 1352-4585. - STAMPA. - 25:(2019), pp. 320-321.

Long-term efficacy and safety of Alemtuzumab in patients with RRMS: 12-year follow-up of the CAMMS223 study

CARRARO, MARCO;FERNANDEZ FLORES, ORLANDO;Massacesi, L;
2019

Abstract

Long-term efficacy and safety of Alemtuzumab in patients with RRMS: 12-year follow-up of the CAMMS223 study
2019
Coles, A; Berkovich, R; Carraro, M; Compston, DAS; Al Malik, Y; Fernandez, O; Ionete, C; Massacesi, L; Meuth, SG; Mitsikostas, D; Pardo, G; Simm, RF; ...espandi
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1177360
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 1
social impact